Pulmonary arterial hypertension (PAH) still remains an incurable disease. The prognostic factors for PAH have been widely studied in many clinical trials for adults. However, the literature lacks clinical trials for determining the prognostic factors in the geriatric population. This article enlists probable PAH prognostic factors, however, derived from standard population, appropriate for elderly population.
Despite the improvements in treatment modalities, pulmonary arterial hypertension (PAH) is still an incurable and fatal disease. Many clinical trials performed on adult population have indicated that the PAH increases with age. Additionally, the presence of other physiological changes developed in the elderly patients (like left ventricular diastolic dysfunction, arterial stiffening, and reduced lung capacity) increases the complexity of clinical findings and prognosis. Doppler…
